| Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease L Jostins, S Ripke, RK Weersma, RH Duerr, DP McGovern, KY Hui, ... Nature 491 (7422), 119-124, 2012 | 5248* | 2012 |
| Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease JC Barrett, S Hansoul, DL Nicolae, JH Cho, RH Duerr, JD Rioux, SR Brant, ... Nature genetics 40 (8), 955-962, 2008 | 3215 | 2008 |
| Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci A Franke, DPB McGovern, JC Barrett, K Wang, GL Radford-Smith, ... Nature genetics 42 (12), 1118-1125, 2010 | 3125 | 2010 |
| Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 CA Anderson, G Boucher, CW Lees, A Franke, M D'Amato, KD Taylor, ... Nature genetics 43 (3), 246-252, 2011 | 1695 | 2011 |
| The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis G Van Assche, A Dignass, J Panes, L Beaugerie, J Karagiannis, M Allez, ... Journal of Crohn's and Colitis 4 (1), 7-27, 2010 | 1341 | 2010 |
| Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease E Louis, A Collard, AF Oger, E Degroote, FAN El Yafi, J Belaiche Gut 49 (6), 777-782, 2001 | 1194 | 2001 |
| Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 J Satsangi, M Parkes, E Louis, L Hashimoto, N Kato, K Welsh, ... Nature genetics 14 (2), 199-202, 1996 | 918 | 1996 |
| Tumour necrosis factor (TNF) gene polymorphism influences TNF‐α production in lipopolysaccharide (LPS)‐stimulated whole blood cell culture in healthy humans Louis, Franchimont, Piron, Gevaert, Roland, Mahieu, Malaise, DE Groote, ... Clinical & Experimental Immunology 113 (3), 401-406, 1998 | 819 | 1998 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 710 | 2021 |
| Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped E Louis, JY Mary, G Vernier–Massouille, JC Grimaud, Y Bouhnik, ... Gastroenterology 142 (1), 63-70. e5, 2012 | 708 | 2012 |
| Development of the Crohn's disease digestive damage score, the Lemann score B Pariente, J Cosnes, S Danese, WJ Sandborn, M Lewin, JG Fletcher, ... Inflammatory bowel diseases 17 (6), 1415-1422, 2011 | 703 | 2011 |
| Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4 C Libioulle, E Louis, S Hansoul, C Sandor, F Farnir, D Franchimont, ... PLoS genetics 3 (4), e58, 2007 | 682 | 2007 |
| Fine-mapping inflammatory bowel disease loci to single-variant resolution H Huang, M Fang, L Jostins, M Umićević Mirkov, G Boucher, ... Nature 547 (7662), 173-178, 2017 | 591 | 2017 |
| Common variants in the NLRP3 region contribute to Crohn's disease susceptibility AC Villani, M Lemire, G Fortin, E Louis, MS Silverberg, C Collette, N Baba, ... Nature genetics 41 (1), 71-76, 2009 | 575 | 2009 |
| Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial JP Galmiche, J Hatlebakk, S Attwood, C Ell, R Fiocca, S Eklund, ... Jama 305 (19), 1969-1977, 2011 | 566 | 2011 |
| Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled … BG Feagan, WJ Sandborn, G D'Haens, J Panés, A Kaser, M Ferrante, ... The Lancet 389 (10080), 1699-1709, 2017 | 453 | 2017 |
| Predictors of severe Crohn's disease C Loly, J Belaiche, E Louis Scandinavian journal of gastroenterology 43 (8), 948-954, 2008 | 387 | 2008 |
| Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal … A Van Gossum, O Dewit, E Louis, G de Hertogh, F Baert, F Fontaine, ... Inflammatory bowel diseases 13 (2), 135-142, 2007 | 373 | 2007 |
| Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: definitions, frequency and pharmacological aspects M Allez, K Karmiris, E Louis, G Van Assche, S Ben-Horin, A Klein, ... Journal of Crohn's and Colitis 4 (4), 355-366, 2010 | 370 | 2010 |
| Genetic markers may predict disease behavior in patients with ulcerative colitis M Roussomoustakaki, J Satsangi, K Welsh, E Louis, G Fanning, S Targan, ... Gastroenterology 112 (6), 1845-1853, 1997 | 358 | 1997 |
